Wang Yi is the founder of NeoCura. NeoCura has raised $38M in total funding. Latest round: Series A. Based in Beijing, China.
Wang Yi is the founder of NeoCura, a Series A company based in Changping, China, established in 2017. NeoCura operates as a provider of an AI-enabled immunotherapy based tumor diagnostic platform, and has raised $38.2M in funding. The company develops cancer therapeutic AI-based platforms and diagnostic tests, including precision medicine products like NeoCura for cancer detection from blood and NeoCura Vac for AI-guided neoantigen therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library